Influenza News and Research

Latest Influenza News and Research

Wal-Mart Stores to offer Tamiflu oral suspension in liquid form for children and elderly

Wal-Mart Stores, Inc. announced today that more than 4,000 Walmart and Sam's Club pharmacies nationwide will address the national shortage of Tamiflu® oral suspension by converting the capsule to liquid form.

12 Oct 2009

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease.

12 Oct 2009

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

A comprehensive study has revealed, for the first time, the impact of swine flu on the health of the general public in Australia and New Zealand.

9 Oct 2009

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

Solvay Pharmaceuticals, Inc. announced that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release Capsules, the most prescribed pancreatic enzyme replacement therapy (PERT) in the United States, significantly improves a key measure of fat absorption in patients with CF who suffer from exocrine pancreatic insufficiency (EPI).

9 Oct 2009

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

MedaSorb Technologies Corporation and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant attached to the Series B financing completed in August 2008. Dr. Phillip Chan, Chief Executive Officer, stated, "We are pleased to have the continued support of our existing investors.

9 Oct 2009

Verichip Corporation's H1N1 virus triage detection system to feature in Fox News

VeriChip Corporation has announced that the Company is scheduled to be featured on the Glenn Beck show on Fox News today, October 8, 2009 during the 5 p.m. hour. Glenn Beck intends to dedicate today's show to the H1N1 virus and will feature VeriChip, its Health Link personal health record and its H1N1 virus triage detection system currently being developed with partner RECEPTORS LLC, as part of the show.

9 Oct 2009

LeVOCC air purification system destroys the PR8 strain of the H1N1 virus

LeVOCC, Inc. today announced that independent laboratory testing has conclusively demonstrated that the LeVOCCTM air purification system successfully destroys a strain of the H1N1 virus. Testing was conducted using the Puerto Rico 8 (PR8) strain of the H1N1 virus. This strain is an influenza A H1N1 seasonal strain and is a valid representative of all H1N1 strains.

9 Oct 2009

Medicago receives contract from U.S. Army Research, Development and Engineering Command laboratory

Medicago Inc. (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate.

9 Oct 2009

St. Petersburg City Council partners with American Lung Association for "Faces of Influenza" campaign

Mayor Rick Baker and members of St. Petersburg City Council are partnering with the American Lung Association in Florida Gulfcoast area on its Faces of Influenza educational initiative to kick off the 2009-2010 influenza season in Tampa/St. Petersburg.

9 Oct 2009

Series of national television public service advertisements to prevent the spread of H1N1 flu virus

Health and Human Services Secretary Kathleen Sebelius announced today that the Department of Health and Human Services (HHS) is joining with The Ad Council to launch a series of national television public service advertisements (PSAs) designed to encourage Americans to take steps to protect themselves from the 2009 H1N1 flu virus.

9 Oct 2009

LeVOCC air purification system destroys H1N1 virus

LeVOCC, Inc. today announced that independent laboratory testing has conclusively demonstrated that the LeVOCC(TM) air purification system successfully destroys a strain of the H1N1 virus.

8 Oct 2009

Experts to develop effective surveillance system to monitor emerging infections at global level

Avian influenza (H5N1), rabies, plague, Bovine Spongiform Encephalopathy (BSE), and more recently swine flu (H1N1) are all examples of diseases that have made the leap from animals to humans.

8 Oct 2009

The Prescription Center Pharmacy launches 'Be Prepared, Not Scared' campaign

The Prescription Center Pharmacy, headquartered in Beverly Hills, California announced its “Be Prepared, Not Scared” campaign today. The purpose of the campaign is to help both businesses and consumers stay healthy, without dramatically changing their daily routines. Dr. Afshin Nassir, the pharmacy’s Founder and CEO, states that “We want to help businesses and consumers create a realistic plan to deal with the H1N1 (Swine Flu) Virus, which is now, according to the Center for Disease Control (CDC), at a Pandemic stage.”

8 Oct 2009

WHO emphasizes H1N1 vaccine safety

The WHO on Tuesday continued to express confidence in the H1N1 (swine flu) vaccine as few mild adverse effects have been reported by patients participating in China's vaccine campaign, the Associated Press reports. Out of the 39,000 people in China who received the H1N1 vaccine, four reported experiencing side effects such as muscle cramps and headache, according to WHO spokesman Gregory Hartl (Higgins, 10/6).

8 Oct 2009

Swine Flu prevention tips from California dentists

In keeping with the global effort to limit the spread of the Swine Flu, the California Dental Hygienists’ Association (CDHA) issued a list today of simple ways patients and oral health professionals can prevent catching and spreading the disease.

8 Oct 2009

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Amarillo Biosciences, Inc. today announced that it has agreed to a strategic partnership with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India, whereby Intas will sponsor clinical trials of ABI's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay ABI a royalty on net sales after marketing approval is obtained in India.

8 Oct 2009

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Peregrine Pharmaceuticals, Inc. today announced that it has established a new Anti-Viral Research Group in its R&D organization.

7 Oct 2009

Microsoft launches a new online H1N1 Flu Response Center

With the current H1N1 flu (swine flu) pandemic under way, many public health officials are concerned that critical healthcare resources could be stretched thin as people flood hospital emergency departments and physicians' offices to determine whether they have the illness.

7 Oct 2009

Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccine

Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.

From Baxter International Inc. 7 Oct 2009

Mexican Health Minister to discuss preparations and responses to H1N1 influenza

Jose Angel Cordova Villalobos, Secretary of Health, United States of Mexico, discussed preparations and responses to the H1N1 influenza during a visit to Washington D.C.

7 Oct 2009

Influenza News and Research

Latest Influenza News and Research

Wal-Mart Stores to offer Tamiflu oral suspension in liquid form for children and elderly

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

A three-month study reveals the impact of swine flu on the health of the general public in Australia and New Zealand

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

Verichip Corporation's H1N1 virus triage detection system to feature in Fox News

LeVOCC air purification system destroys the PR8 strain of the H1N1 virus

Medicago receives contract from U.S. Army Research, Development and Engineering Command laboratory

St. Petersburg City Council partners with American Lung Association for "Faces of Influenza" campaign

Series of national television public service advertisements to prevent the spread of H1N1 flu virus

LeVOCC air purification system destroys H1N1 virus

Experts to develop effective surveillance system to monitor emerging infections at global level

The Prescription Center Pharmacy launches 'Be Prepared, Not Scared' campaign

WHO emphasizes H1N1 vaccine safety

Swine Flu prevention tips from California dentists

Amarillo Biosciences, Intas Pharmaceuticals enter strategic partnership to combat influenza in India

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Microsoft launches a new online H1N1 Flu Response Center

Baxter receives marketing authorization for CELVAPAN H1N1 pandemic influenza vaccine

Mexican Health Minister to discuss preparations and responses to H1N1 influenza

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Influenza News and Research

Latest Influenza News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in